Hung‐Wei Wang
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Cytomegalovirus and herpesvirus research
Papers in
- Epidemiology 18
- Liver Disease Diagnosis and Treatment 13
- Hepatitis B Virus Studies 6
- Cytomegalovirus and herpesvirus research 3
- Hepatology 14
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Hepatitis C virus research 5
- Co-authors
- Cheng‐Yuan Peng (22 shared papers)Wei‐Fan Hsu (20 shared papers)Guan‐Tarn Huang (12 shared papers)Hsueh‐Chou Lai (18 shared papers)Wen‐Pang Su (16 shared papers)Sheng‐Hung Chen (13 shared papers)Po‐Heng Chuang (11 shared papers)Ting‐Yi Wang (1 shared paper)
- Journals
- PLoS ONE (4 papers)Medicine (3 papers)Cancers (3 papers)Liver Cancer (1 paper)Canadian Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Hung‐Wei Wang
35 papers receiving 394 citations
Peers
Comparison fields: 5 of 61
- Hepatology 159
- Epidemiology 182
- Nephrology 19
- Pathology and Forensic Medicine 30
- Cancer Research 24
Countries citing papers authored by Hung‐Wei Wang
This map shows the geographic impact of Hung‐Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Wei Wang more than expected).
Fields of papers citing papers by Hung‐Wei Wang
This network shows the impact of papers produced by Hung‐Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Wei Wang. The network helps show where Hung‐Wei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hung‐Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 45 | |
| 2 | 2015 | 41 | |
| 3 | 2017 | 40 | |
| 4 | 2015 | 30 | |
| 5 | 2023 | 30 | |
| 6 | 2018 | 22 | |
| 7 | Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies. | 2021 | 17 |
| 8 | 2019 | 16 | |
| 9 | Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience. | 2020 | 16 |
| 10 | 2023 | 15 | |
| 11 | 2020 | 13 | |
| 12 | 2021 | 12 | |
| 13 | 2018 | 11 | |
| 14 | 2016 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2024 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2022 | 7 | |
| 20 | 2017 | 5 |
About Hung‐Wei Wang
Hung‐Wei Wang is a scholar working on Epidemiology, Hepatology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 37 papers that have together received 400 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (5 papers), Cancer, Lipids, and Metabolism (4 papers), Cytomegalovirus and herpesvirus research (3 papers), Renal cell carcinoma treatment (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Hepatology (159 citations), Epidemiology (182 citations), Nephrology (19 citations), Pathology and Forensic Medicine (30 citations) and Cancer Research (24 citations). Hung‐Wei Wang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Cheng‐Yuan Peng, Wei‐Fan Hsu, Guan‐Tarn Huang, Hsueh‐Chou Lai, Wen‐Pang Su, Sheng‐Hung Chen, Po‐Heng Chuang, Ting‐Yi Wang, Ming‐Yao Su and Chia‐Hsin Lin. Their work appears in journals such as PLoS ONE, Medicine, Cancers, Liver Cancer and Canadian Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.